axitinib

Axitinib is an indazole derivative. It is most commonly marketed under the name Inlyta® and is available in oral formulations._x000D_ Axitinib is a second generation tyrosine kinase inhibitor that works by selectively inhibiting vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3).7. Reference standards of Axitinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => 6-Iodo-1H-indazole
    [catalogue_number] => PA 28 45650
    [category_ids] => ,79,80,71,84,
    [chemical_name] => 
    [weight] => 244.03
    [form] => C7H5IN2
    [cas] => 261953-36-0
    [pslug] => 261953-36-0-6-iodo-1h-indazole-pa2845650
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

6-Iodo-1H-indazole

Catalogue No.:PA 28 45650
CAS :
261953-36-0
Molecular Formula : C₇H₅IN₂
Molecular Weight : 244.03

Enquire

Details

stdClass Object
(
    [pname] => 3,6-Diiodo-1H-indazole
    [catalogue_number] => PA 28 45660
    [category_ids] => ,79,80,71,84,
    [chemical_name] => 
    [weight] => 369.93
    [form] => C7H4I2N2
    [cas] => 319472-78-1
    [pslug] => 319472-78-1-3-6-diiodo-1h-indazole-pa2845660
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)